UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2013-09-09 Downgrade Dougherty & Company Buy to Neutral
2013-03-21 Initiated Dougherty & Company Buy $12.50
2012-09-24 Upgrade Oppenheimer Perform to Outperform $19
2012-06-19 Downgrade Robert W. Baird Outperform to Neutral $25 to $9
2012-06-19 Downgrade Oppenheimer Outperform to Perform
2012-05-09 Reiterated Avondale Mkt Perform $24 to $17
2012-05-01 Reiterated Avondale Mkt Perform $34 to $37
2011-12-21 Reiterated Avondale Mkt Outperform $26 to $30
2011-04-19 Initiated Avondale Mkt Outperform $30
2011-03-25 Reiterated Oppenheimer Outperform $20 to $25
2011-03-22 Initiated Oppenheimer Outperform $20
2013-09-09 Downgrade Dougherty & Company Buy to Neutral
2013-03-21 Initiated Dougherty & Company Buy $12.50
2012-09-24 Upgrade Oppenheimer Perform to Outperform $19
2012-06-19 Downgrade Robert W. Baird Outperform to Neutral $25 to $9
2012-06-19 Downgrade Oppenheimer Outperform to Perform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In BODY 0 funds of 2210 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
Rosenbaum Jerrold 1.20%  (206742) BODY /
Angelo Beth EVP & Chief Merchandising Ofcr 0.50%  (86777) BODY /
DOOLAN MARTIN P 0.26%  (44912) BODY /
ECTON DONNA R 0.18%  (30457) BODY / KAR / UAN /
GLASS ROBERT 0.16%  (27469) BODY /
KATZ DAVID A. 0.14%  (24651) BODY /
Stoltz Thomas W Chief Financial Officer 0.13%  (22471) BODY /
Weinstein Allen President & CEO 0.12%  (20972) BODY / DEST /
Gallin Scott 0.12%  (20355) BODY /
Salopek Jennifer C 0.10%  (16661) BODY /
Haley John K 0.08%  (14122) BODY / GGP /
SWARTWOOD MATTHEW Senior Vice President, Sales 0.05%  (7972) BODY /
Simigran Patti SVP, GMM 0.02%  (3704) BODY /

Comments